(Q80388285)
Statements
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts (English)
Hajnalka Andrikovics
Sarolta Nahajevszky
Anikó Szilvási
András Bors
Emma Adám
András Kozma
Béla Kajtár
Anikó Barta
Anna Poros
1 September 2007